TRENTON, N.J. (AP) - Five large drug and grocery chains are suing Pfizer Inc. and a second drugmaker, alleging they conspired to delay sales of cheap generic versions of the blockbuster cholesterol drug Lipitor.
Lipitor, the world’s top-selling drug ever, got U.S. generic competition on Nov. 30.
The lawsuit accuses Pfizer of patent fraud as well as “illegal, anti-competitive conduct” with generic drugmaker Ranbaxy Laboratories to block other generic drugmakers from selling versions of Lipitor until recently. The suit also accuses Pfizer of making deals with prescription benefit managers to limit sales of generic Lipitor.
By Elaine Donnelly
Extending sexual misconduct to combat units
Independent voices from the TWT Communities
An establishmentarian conservative, short on cash, but long on wisdom.
First over-the-counter column approved for fast and effective relief from even your worst media-induced headache.
A collection of reader guest articles, thoughts and opinions by Communities writers and breaking news and information.
Benghazi: The anatomy of a scandal
Vietnam Memorial adds four names
Cinco de Mayo on the Mall
NRA kicks off annual convention